Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
VALEANT PHARMA I RG (NY: VRX)
23.40 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 8:04 PM EDT, Jul 13, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open 23.40
Bid (Size) 23.36 (600)
Ask (Size) 23.40 (1000)
Prev. Close 23.40
Today's Range 23.40 - 23.40
52wk Range 10.94 - 27.79
Shares Outstanding 348,708,567
Dividend Yield N/A
Performance
YTD
+7.39%
+7.39%
1 Month
-0.68%
-0.68%
3 Month
+35.81%
+35.81%
6 Month
+1.83%
+1.83%
1 Year
+34.72%
+34.72%
Top News
More News
Bausch + Lomb Announces U.S. FDA Filing Acceptance For Loteprednol Etabonate Ophthalmic Gel, 0.38%
Bausch + Lomb, a leading global eye health company and wholly owned subsidiary of Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX), today announced that the U.S. Food and Drug Administration... Read More
from PR Newswire
Salix And US WorldMeds Enter Into Exclusive Co-Promotion Agreement For Opioid Withdrawal Treatment LUCEMYRA™ (lofexidine)
Salix Sales Force to Begin Promoting LUCEMYRA to Primary Care and Pain Management Physicians Read More
from PR Newswire
More News
Read More
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valeant Pharmaceuticals International, Inc. - VRX
from ACCESSWIRE
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valeant Pharmaceuticals International, Inc. - VRX
from PR Newswire
TD Ameritrade Traders Adopt Some Old And New Approaches To The Trade War Market In June's IMX
category M , CRON , MU , and 19 more.
from Benzinga
Interesting VRX Put And Call Options For August 10th
category Stocks
from Market News Video
2,800 Tuesday and the S&P – Are We There Yet?
category ETFs , Stocks / Equities , Futures
from Blogs - TalkMarkets
Valeant is back on to its old drug-pricing ways
category Medical Products , DJIA , SPX , and 4 more.
from MarketWatch
Reviewing Bill Ackman's Q1 Trading Activity: Sells Nike and Howard Hughes
category CMG , MDLZ , General , and 12 more.
from Benzinga
3 Biotech Stocks With Major Catalysts Incoming
category Market News , VRX , PFE , and 3 more.
from Motley Fool
Top Buys by Directors: Papa's $481.5K Bet on VRX
category Stocks
from Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.